LITS · LITE STRATEGY INC
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
9920 Pacific Heights Blvd., San Diego, CA, 92121, United States
Biotechnology
Healthcare
Market Cap
25.6M
52 Wk Range
$0.69 - $2.00
Previous Close
$0.86
Open
$0.85
Volume
267,832
Day Range
$0.76 - $0.85
Enterprise Value
21.31M
Cash
4.281M
Avg Qtr Burn
-2.176M
Insider Ownership
1.40%
Institutional Own.
16.49%
Qtr Updated
Sep 30th 2026
